Health Care & Life Sciences » Biotechnology | China Regenerative Medicine International Ltd.

China Regenerative Medicine International Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
69,374.00
275,248.00
272,528.00
191,198.00
171,826.00
1,352,799
Depreciation, Depletion & Amortization
18,640.00
30,464.00
48,864.00
51,783.00
40,922.00
69,596
Other Funds
-
3,507.00
-
-
472,542.00
922,853
Funds from Operations
59,721.00
98,796.00
122,050.00
145,579.00
135,481.00
360,350
Changes in Working Capital
34,720.00
29,570.00
97,857.00
113,314.00
82,274.00
290,376
Net Operating Cash Flow
94,441.00
128,366.00
219,907.00
32,265.00
217,755.00
69,974
Capital Expenditures
11,164.00
22,531.00
43,777.00
38,303.00
9,542.00
Sale of Fixed Assets & Businesses
-
1,890.00
28,122.00
3,469.00
24,925.00
Purchase/Sale of Investments
4,800.00
-
-
-
475,291.00
Net Investing Cash Flow
15,926.00
20,641.00
45,175.00
75,118.00
559,908.00
Issuance/Reduction of Debt, Net
855.00
525.00
21,577.00
486,012.00
28,345.00
Net Financing Cash Flow
342,994.00
4,032.00
1,154,743.00
942,118.00
444,197.00
Net Change in Cash
232,627.00
153,309.00
889,966.00
828,092.00
327,359.00
Free Cash Flow
105,605.00
145,226.00
256,391.00
66,547.00
223,822.00
Net Assets from Acquisitions
-
-
6,898.00
40,284.00
100,000.00
Other Sources
38.00
-
-
-
-
Change in Capital Stock
342,139.00
-
1,133,166.00
456,106.00
-
Exchange Rate Effect
-
270.00
305.00
6,643.00
6,107.00
Other Uses
-
-
22,622.00
-
-

About China Regenerative Medicine International

View Profile
Address
Rooms 3006-10, 30/F
Hong Kong
Hong Kong
Employees -
Website http://www.crmi.hk
Updated 07/08/2019
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development, production and sales of tissue engineering and regenerative medicine products. It operates through the following business segments: Tissue Engineering, Cell, and Cosmetic and Others, and Medical Equipment. The Tissue Engineering segment produces and sells tissue.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.